SAIC reported stronger-than-expected Q2 results, topping consensus and raising its FY27 guidance to $10.65-$10.75 in adjusted EPS and $7.2B-$7.3B in revenue. The upgrade signals durable demand, potential margin expansion, and effective execution. With UBS and Truist increasing price targets, the stock could re-rate higher if execution remains on track, though the near-term reaction was modestly negative.
SAIC posted a solid second quarter, delivering $1.88B in revenue (+6.3% YoY) with 5.3% organic growth and $102M net income. Adjusted EBITDA reached $193M (10.3% margin) as the firm raised its FY2027 guidance to $7.2–$7.3B in revenue and $750–$755M of adjusted EBITDA, with free cash flow above $600M. Backlog sits at $22.1B, including $3.8B funded, underpinned by multiple award wins in US Space/INT, Army and Navy, plus a MARPA facility upgrade and a quarterly dividend increase.
Science Applications International Corporation (SAIC) will announce its Q4 earnings on March 16, potentially influencing share price due to market expectations. Given historical volatility surrounding earnings announcements, investors should remain alert to potential price fluctuations following the report.
SAIC's Q2 sales declined 3% to $1.77 billion, missing estimates. Adjusted EPS of $3.63 beat expectations of $2.24. 2026 revenue outlook revised down to $7.250-$7.325 billion. Annual adjusted EPS outlook increased to $9.40-$9.60, beating consensus. SAIC shares fell 1.7% after the earnings announcement.